With major infrastructure projects complete, Hess Midstream pivots to a capital-light strategy, prioritizing cash returns and debt reduction. Chevron's indirect stake adds a new dimension to the company's financial priorities.
Aquestive Therapeutics faces a regulatory delay for its sublingual epinephrine film, Anaphylm, after the FDA raised concerns primarily about its packaging and labeling. The company views the issues as solvable and is moving forward with redesigns and new studies, aiming for a 2026 resubmission while advancing parallel filings abroad.
Nike is consolidating its outdoor ambitions, merging its ACG and trail running lines into a dedicated performance brand. The strategic pivot targets a lucrative market as the sportswear giant seeks to reinvigorate growth against a backdrop of a multi-year stock decline.
UnitedHealth Group shares have tumbled nearly 47% over the past year, significantly underperforming the broader market and raising urgent questions about its valuation. While a standard discounted cash flow model suggests the stock is deeply undervalued, investors are weighing the model's optimistic assumptions against mounting regulatory and operational headwinds in the healthcare sector.
Following its annual results showing $5 billion in revenue, Antero Resources (AR) faces a valuation conundrum as its share price weakens. While long-term returns remain stellar, recent momentum has cooled, raising questions about its fair value in a shifting energy landscape.
A wave of panic selling has engulfed the software sector, with even giants like Microsoft not spared. Investors are fleeing on fears that artificial intelligence will erode pricing power, competitive advantages, and long-term growth, creating what traders are calling a 'SaaSpocalypse'.
Elon Musk's artificial intelligence venture, xAI, is launching a major recruitment drive for cryptocurrency and traditional finance experts to train its AI models. This strategic push coincides with the company's impending $1 trillion merger with SpaceX, signaling a deeper integration of Musk's tech and financial ambitions.
Stani Kulechov, founder of the decentralized finance protocol Aave, has purchased a luxury five-story residence in London's Notting Hill for £22 million, reportedly below asking price, as crypto entrepreneurs increasingly invest in traditional real estate assets.
CNBC's Jim Cramer suggests that upcoming clinical trial updates for Eli Lilly's GLP-1 drugs, rather than quarterly earnings, are the primary catalyst investors should watch for potential stock movement.
CNBC's Jim Cramer has added Amgen to his watchlist, expressing strong confidence in the biotech giant's future following positive updates at the JPMorgan Healthcare Conference. He specifically highlighted the strength of the company's development pipeline.
CNBC's Jim Cramer suggests Chipotle Mexican Grill's stock, despite potential for a muted quarter, may be poised for a rebound given its depressed valuation, highlighting it in his weekly market game plan.
CNBC's Jim Cramer has spotlighted Merck & Co. as a strategic holding, praising the pharmaceutical giant's acquisition-driven strategy to build a more balanced portfolio ahead of its blockbuster drug's patent cliff.
CNBC's Jim Cramer has placed Palantir Technologies on his radar ahead of its quarterly report, expressing confidence in the data analytics firm's performance and highlighting the combative leadership style of CEO Alex Karp.
As The Walt Disney Company prepares to report earnings, CNBC's Jim Cramer places the media giant under scrutiny, highlighting persistent challenges in its streaming business and theme park operations that investors will be watching closely.
As the artificial intelligence boom enters a new phase of enterprise deployment, investors are looking beyond pure software to the foundational hardware layer. We analyze three key companies powering the AI revolution and why their roles may offer a compelling, lower-risk investment thesis this February.
U.S. stock futures ticked up Tuesday as investors braced for a heavy slate of corporate results, while a partial government shutdown forced a delay of January's crucial employment report, adding uncertainty to the economic outlook.
Despite a strong year of outperformance for automotive safety giant Autoliv, investment firm Tweedy Browne has significantly reduced its holding, sparking debate on whether the move signals caution or prudent portfolio management.
Residents in Clayton County, Georgia, are reeling from unexplained water bill spikes reaching nearly $1,000 monthly, despite no evidence of leaks. As officials promote a county-wide smart meter upgrade, homeowners demand answers and refunds for what they call erroneous charges.
Amazon has shattered its own delivery speed records, completing over 13 billion same- or next-day deliveries globally in 2025, intensifying the logistics arms race with Walmart and reshaping consumer expectations for instant fulfillment.
French prosecutors have conducted searches at the Paris offices of social media platform X, advancing an investigation into the alleged dissemination of child sexual abuse material and AI-generated deepfakes. The probe, which also examines Holocaust denial content from the platform's Grok AI, signals escalating regulatory pressure on Elon Musk's company in Europe.
